RICK SESSIONS: Open Payments
NPI 1780634949 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 36 payments from 22 companies in 2025. Trend: 2023 $713 · 2024 $699 · 2025 $844
Food & beverage: $844
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $82 |
| PFIZER INC. | 3 | $71 |
| Merck Sharp & Dohme LLC | 2 | $59 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| Janssen Biotech, Inc. | 2 | $49 |
| Genentech USA, Inc. | 2 | $47 |
| Incyte Corporation | 2 | $46 |
| ABBVIE INC. | 2 | $37 |
| Teleflex LLC | 1 | $36 |
Products named: Nubeqa, XTANDI, NINLARO, PLUVICTO, EPKINLY, BARRIGEL, ORGOVYX, LYNPARZA.
Industry payments across FL — which companies pay providers there.
